Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

Similar articles for PubMed (Select 22712058)

1.

Second trimester anti-angiogenic proteins and preeclampsia.

Haggerty CL, Seifert ME, Tang G, Olsen J, Bass DC, Karumanchi SA, Ness RB.

Pregnancy Hypertens. 2012 Apr 1;2(2):158-163.

2.

Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.

Govender N, Naicker T, Rajakumar A, Moodley J.

Eur J Obstet Gynecol Reprod Biol. 2013 Sep;170(1):100-5. doi: 10.1016/j.ejogrb.2013.05.021. Epub 2013 Jun 24.

PMID:
23806447
3.

Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies.

Powers RW, Jeyabalan A, Clifton RG, Van Dorsten P, Hauth JC, Klebanoff MA, Lindheimer MD, Sibai B, Landon M, Miodovnik M; Eunice Kennedy Shriver National Institute of Child Health Human Development Maternal-Fetal Medicine Units Network.

PLoS One. 2010 Oct 11;5(10):e13263. doi: 10.1371/journal.pone.0013263.

4.

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA; CPEP Study Group.

N Engl J Med. 2006 Sep 7;355(10):992-1005. Erratum in: N Engl J Med. 2006 Oct 26;355(17):1840.

5.

Circulating anti-angiogenic factors during hypertensive pregnancy and increased risk of respiratory distress syndrome in preterm neonates.

Wang A, Holston AM, Yu KF, Zhang J, Toporsian M, Karumanchi SA, Levine RJ.

J Matern Fetal Neonatal Med. 2012 Aug;25(8):1447-52. doi: 10.3109/14767058.2011.640368. Epub 2011 Dec 13.

6.

Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.

Moore Simas TA, Crawford SL, Bathgate S, Yan J, Robidoux L, Moore M, Maynard SE.

J Matern Fetal Neonatal Med. 2014 Jul;27(10):1038-48. doi: 10.3109/14767058.2013.847415. Epub 2013 Oct 29.

PMID:
24066977
7.

Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion.

Stepan H, Geipel A, Schwarz F, Krämer T, Wessel N, Faber R.

Am J Obstet Gynecol. 2008 Feb;198(2):175.e1-6. doi: 10.1016/j.ajog.2007.08.052.

PMID:
18226617
8.

Maternal, gestational and neonatal characteristics and maternal angiogenic factors in normotensive pregnancies.

Staff AC, Harsem NK, Braekke K, Hyer M, Hoover RN, Troisi R.

Eur J Obstet Gynecol Reprod Biol. 2009 Mar;143(1):29-33. doi: 10.1016/j.ejogrb.2008.11.003. Epub 2009 Jan 8.

PMID:
19135290
9.

First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia.

Baumann MU, Bersinger NA, Mohaupt MG, Raio L, Gerber S, Surbek DV.

Am J Obstet Gynecol. 2008 Sep;199(3):266.e1-6. doi: 10.1016/j.ajog.2008.06.069.

PMID:
18771978
10.

Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women.

Levine RJ, Qian C, Maynard SE, Yu KF, Epstein FH, Karumanchi SA.

Am J Obstet Gynecol. 2006 Apr;194(4):1034-41.

PMID:
16580293
11.

Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia.

Rana S, Cerdeira AS, Wenger J, Salahuddin S, Lim KH, Ralston SJ, Thadhani RI, Karumanchi SA.

PLoS One. 2012;7(10):e48259. doi: 10.1371/journal.pone.0048259. Epub 2012 Oct 26.

12.

Serum sFlt1:PlGF ratio, PlGF, and soluble endoglin levels in gestational proteinuria.

Ohkuchi A, Hirashima C, Matsubara S, Suzuki H, Takahashi K, Usui R, Suzuki M.

Hypertens Pregnancy. 2009 Feb;28(1):95-108. doi: 10.1080/10641950802419895.

PMID:
19165674
13.

Effect of smoking on circulating angiogenic factors in high risk pregnancies.

Jeyabalan A, Powers RW, Clifton RG, Van Dorsten P, Hauth JC, Klebanoff MA, Lindheimer MD, Sibai B, Landon M, Miodovnik M; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.

PLoS One. 2010 Oct 12;5(10):e13270. doi: 10.1371/journal.pone.0013270.

14.

Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia.

Rana S, Karumanchi SA, Levine RJ, Venkatesha S, Rauh-Hain JA, Tamez H, Thadhani R.

Hypertension. 2007 Jul;50(1):137-42. Epub 2007 May 21.

15.

[Angiogenic factors and their role in pathogenesis and prediction of preeclampsia].

Stepan H, Jank A.

Z Geburtshilfe Neonatol. 2009 Jun;213(3):101-5. doi: 10.1055/s-0029-1224142. Epub 2009 Jun 17. Review. German.

PMID:
19536710
16.

Soluble endoglin for the prediction of preeclampsia in a high risk cohort.

Maynard SE, Moore Simas TA, Bur L, Crawford SL, Solitro MJ, Meyer BA.

Hypertens Pregnancy. 2010;29(3):330-41. doi: 10.3109/10641950902968684.

PMID:
20670156
17.

Human chorionic gonadotropin, angiogenic factors, and preeclampsia risk: a nested case-control study.

Asvold BO, Eskild A, Vatten LJ.

Acta Obstet Gynecol Scand. 2014 May;93(5):454-62. doi: 10.1111/aogs.12363.

PMID:
24575980
18.

PP176. SFLT-1: A possibility of precocious diagnosis of preeclampsia.

Olmos CS, Macedo MA, Pereira RM, Augusto V, Garcia JM, Panico VJ, Souza EV, Sato JL, Saito M, Sousa FL, Sass N.

Pregnancy Hypertens. 2012 Jul;2(3):335-6. doi: 10.1016/j.preghy.2012.04.287. Epub 2012 Jun 13.

PMID:
26105497
19.

Angiogenic biomarkers for prediction of maternal and neonatal complications in suspected preeclampsia.

Moore AG, Young H, Keller JM, Ojo LR, Yan J, Simas TA, Maynard SE.

J Matern Fetal Neonatal Med. 2012 Dec;25(12):2651-7. doi: 10.3109/14767058.2012.713055. Epub 2012 Aug 22.

PMID:
22861812
20.

Alteration of serum soluble endoglin levels after the onset of preeclampsia is more pronounced in women with early-onset.

Hirashima C, Ohkuchi A, Matsubara S, Suzuki H, Takahashi K, Usui R, Suzuki M.

Hypertens Res. 2008 Aug;31(8):1541-8. doi: 10.1291/hypres.31.1541.

PMID:
18971528
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk